Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (201-210 of 862) with videos related to

Pageof 87
Sort By:
International Journal of Alzheimer'S Disease|January 22, 2011
Brain imaging of nicotinic receptors in Alzheimer's diseaseJin Wu, Masatomo Ishikawa, Jichun Zhang, et al.
Journal of Affective Disorders|May 8, 2020
Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: A role of brain-spleen axisJiancheng Zhang, Lijia Chang, Yaoyu Pu, et al.
The International Journal of Neuropsychopharmacology|July 23, 2018
Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress ModelKai Zhang, Min Ma, Chao Dong, et al.
Plos One|July 4, 2008
Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathwaysTomoko Nishimura, Tamaki Ishima, Masaomi Iyo, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 20, 2007
[Development of new drugs targeting glial cells]Yoshihisa Kudo, Schuichi Koizumi, Keiji Wada, et al.
The Journal of Craniofacial Surgery|January 25, 2003
Malignant fibrous histiocytoma of scalp with intracranial invasion 20 years after postoperative irradiationJunji Hayami, Ichiro Kurokawa, Kenji Hashimoto, et al.
Translational Psychiatry|November 9, 2019
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolitesChun Yang, Jianjun Yang, Ailin Luo, et al.
Glia|February 25, 2006
Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factorsYoshinori Hayashi, Hitoshi Ishibashi, Kenji Hashimoto, et al.
Neuroscience and Biobehavioral Reviews|May 14, 2025
Demyelination in psychiatric and neurological disorders: Mechanisms, clinical impact, and novel therapeutic strategiesRumi Murayama, Yi Cai, Hiroyuki Nakamura, et al.
Pharmacology, Biochemistry, and Behavior|December 10, 2013
R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamineJi-Chun Zhang, Su-Xia Li, Kenji Hashimoto
Pageof 87

Showing results (201-210 of 862) with videos related to

Sort By:
Pageof 87
International Journal of Alzheimer'S Disease|January 22, 2011
Brain imaging of nicotinic receptors in Alzheimer's diseaseJin Wu, Masatomo Ishikawa, Jichun Zhang, et al.
Journal of Affective Disorders|May 8, 2020
Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: A role of brain-spleen axisJiancheng Zhang, Lijia Chang, Yaoyu Pu, et al.
The International Journal of Neuropsychopharmacology|July 23, 2018
Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress ModelKai Zhang, Min Ma, Chao Dong, et al.
Plos One|July 4, 2008
Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathwaysTomoko Nishimura, Tamaki Ishima, Masaomi Iyo, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 20, 2007
[Development of new drugs targeting glial cells]Yoshihisa Kudo, Schuichi Koizumi, Keiji Wada, et al.
The Journal of Craniofacial Surgery|January 25, 2003
Malignant fibrous histiocytoma of scalp with intracranial invasion 20 years after postoperative irradiationJunji Hayami, Ichiro Kurokawa, Kenji Hashimoto, et al.
Translational Psychiatry|November 9, 2019
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolitesChun Yang, Jianjun Yang, Ailin Luo, et al.
Glia|February 25, 2006
Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factorsYoshinori Hayashi, Hitoshi Ishibashi, Kenji Hashimoto, et al.
Neuroscience and Biobehavioral Reviews|May 14, 2025
Demyelination in psychiatric and neurological disorders: Mechanisms, clinical impact, and novel therapeutic strategiesRumi Murayama, Yi Cai, Hiroyuki Nakamura, et al.
Pharmacology, Biochemistry, and Behavior|December 10, 2013
R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamineJi-Chun Zhang, Su-Xia Li, Kenji Hashimoto
Pageof 87